BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3983371)

  • 1. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
    Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
    Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells.
    Rasey JS; Grunbaum Z; Magee S; Nelson NJ; Olive PL; Durand RE; Krohn KA
    Radiat Res; 1987 Aug; 111(2):292-304. PubMed ID: 3628717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids.
    Sutherland RM; Bareham BJ; Reich KA
    Cancer Clin Trials; 1980; 3(1):73-83. PubMed ID: 7389039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of misonidazole adducts in 9L gliosarcoma tumors and spheroids: implications for oxygen distribution.
    Franko AJ; Koch CJ; Boisvert DP
    Cancer Res; 1992 Jul; 52(14):3831-7. PubMed ID: 1617656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional [14C]misonidazole distribution in experimental RT-9 brain tumors.
    Horowitz M; Blasberg R; Molnar P; Strong J; Kornblith P; Pleasants R; Fenstermacher J
    Cancer Res; 1983 Aug; 43(8):3800-7. PubMed ID: 6861144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Killing of EMT-6 cells by decays from isotopes incorporated on sensitizer adducts.
    Roa WH; Chapman JD
    Radiat Res; 1992 Nov; 132(2):248-53. PubMed ID: 1438707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
    Garrecht BM; Chapman JD
    Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromomisonidazole: synthesis and characterization of a new radiosensitizer.
    Rasey JS; Krohn KA; Freauff S
    Radiat Res; 1982 Sep; 91(3):542-54. PubMed ID: 7122830
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between the binding of [3H]misonidazole and AF-2 in Chinese hamster V79 spheroids.
    Olive PL; Rasey JS; Durand RE
    Radiat Res; 1986 Jan; 105(1):105-14. PubMed ID: 3945722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the hypoxic radiosensitizers misonidazole and demethylmisonidazole after intraperitoneal administration in humans.
    Gianni L; Jenkins JF; Greene RF; Lichter AS; Myers CE; Collins JM
    Cancer Res; 1983 Feb; 43(2):913-6. PubMed ID: 6848201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
    Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
    Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
    Shibamoto Y; Ono K; Takahashi M; Kano E; Hori H; Shibata T; Inayama S; Abe M
    Jpn J Cancer Res; 1986 Oct; 77(10):1027-33. PubMed ID: 3096918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of congeners of misonidazole for imaging hypoxia.
    Grunbaum Z; Freauff SJ; Krohn KA; Wilbur DS; Magee S; Rasey JS
    J Nucl Med; 1987 Jan; 28(1):68-75. PubMed ID: 3794812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the fate of misonidazole (RO 07-0582) and its metabolite desmethylmisonidazole (RO 05-9963), two hypoxic cell radiosensitizers: penetration properties in tumor bearing rats.
    Akel G; Canal P; Mockey E; Vandevoorde E; Laurent F; Soula G
    J Pharmacol; 1983; 14(1):67-77. PubMed ID: 6834852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.